Bristol-Myers extends expiration date for Celgene notes to September 30

Bristol-Myers Squibb (NYSE:BMY) has extended the expiration date of the Exchange Notes offering issued by Celgene (NASDAQ:CELG) for up to $19.85B of new BMY to September 30 from July 8.

The settlement date is expected to occur promptly after the Expiration Date and closing date of the Merger, at the end of 2019 or the beginning of 2020. As a result, the Expiration Date may be further extended one or more times.

https://seekingalpha.com/news/3474582-bristol-myers-extends-expiration-date-celgene-notes-september-30